A note on performance metrics for the Kidney Failure Risk Equation
Nephrol Dial Transplant
.
2024 Aug 30;39(9):1523-1525.
doi: 10.1093/ndt/gfae098.
Authors
Oskar Ålund
1
,
Robert Unwin
2
,
Benjamin Challis
2
,
Philip A Kalra
3
,
Maarten W Taal
4
,
David C Wheeler
5
,
Simon D S Fraser
6
,
Paul Cockwell
7
,
Magnus Söderberg
1
Affiliations
1
AstraZeneca, Gothenburg, Sweden.
2
AstraZeneca, Cambridge, UK.
3
Department of Renal Medicine, Salford Royal Hospital and University of Manchester, Manchester, UK.
4
Centre for Kidney Research and Innovation, University of Nottingham, Nottingham, UK.
5
Department of Renal Medicine, University College London, London, UK.
6
School of Primary Care, Population Science and Medical Education, Faculty of Medicine, University of Southampton, Southampton, UK.
7
Department of Renal Medicine, Queen Elizabeth Hospital, University Hospitals of Birmingham, Birmingham, UK.
PMID:
38678004
DOI:
10.1093/ndt/gfae098
No abstract available
Publication types
Editorial
Letter
MeSH terms
Benchmarking
Glomerular Filtration Rate*
Humans
Kidney Failure, Chronic / therapy
Renal Insufficiency / diagnosis
Renal Insufficiency / etiology
Risk Assessment / methods
Risk Factors
Grants and funding
AbbVie
AstraZeneca
Evotec International GmbH
Travere Therapeutics
UCB Biopharma